SWS Academic Research eLibraryEarth & Planetary Sciences

Scholarly record

MICROBIOLOGICAL QUALITY OF SOME COMMERCIAL SORTS OF CALENDULAE FLOS AND THE INFLUENCE ON CHEMICAL COMPOSITION

Mircea, Cornelia, Cioanca, Oana, Tuchilus, Cistina, Hancianu, Monica, Tataranga, Gabriela

First published: 2013-06-20https://doi.org/10.5593/sgem2013/be5.v1/s20.091View metrics

Publication Impact Profile

PlumX
  • Captures
  • Mendeley - Readers: 3

Publication details

Title
MICROBIOLOGICAL QUALITY OF SOME COMMERCIAL SORTS OF CALENDULAE FLOS AND THE INFLUENCE ON CHEMICAL COMPOSITION
Authors
Mircea, Cornelia, Cioanca, Oana, Tuchilus, Cistina, Hancianu, Monica, Tataranga, Gabriela
Proceedings
SGEM International Multidisciplinary Scientific GeoConference EXPO Proceedings; 13th SGEM GeoConference on ECOLOGY, ECONOMICS, EDUCATION AND LEGISLATION
Publisher
Stef92 Technology
Year
2013
Pages
693 - 700 pp
ISSN
1314-2704
ISBN
Not available yet
Language
en
Publication type
Conference Paper
References20
  1. . Behtash N., Shafaroudi H., Nazari Khorasgani Z. Analgesic effect of Calendula officinalis flowers extract in mice, Toxicology Letters, Ireland, vol. 196/Supplement, pp. S251, 2010.

  2. . Bugno A., Almodovar B., Aparecida A., Pereira Caldas T et al. Occurence of toxigenic fungi in herbal drugs, Brazilian Journal of Microbiology, Brazil, vol. 37, pp. 47-51, 2006, 37.

  3. . Cordova C.A., Siqueira I.R., Netto Ca., Yunes R.A. et al. Protective properties of butanolic extract of the Calendula officinalis L. (marigold) against lipid peroxidation of rat liver microsomes and action as free radical scavanger, Redox Report, Australia, vol. 7/issue 2, pp. 95-102, 2002.

  4. . Czech E., Kneifel W., Kopp B. Microbiological status of commercially available medicinal drugs-a screening study, Planta Medica, Germany, vol. 67/issue 3, pp. 263- 269, 2001.

  5. . Efstratiou E., Abdullah I.H., Poonam S.N., Moore J.E., Muhammad A.A., Juluri R.R. Antimicrobial activity of Calendula officinalis petal extracts against fungi, as well as Gram-negative and Gram -positive clinical pathogens, Complementary Therapies i n Clinical Practice, United Kingdom, Vol. 18/Issue 3, pp. 173-176, 2012.

  6. . Goncalez E., Felicio J.D., Pinto M.M. Bioflavonoids inhibit the production of aflatoxin by Aspergillus flavus, Brazilian Journal of Medical and Biological Research, Brazil, vol. 34/issue 11, pp. 1453-1456, 2001.

  7. . Halt M. Moulds and mycotoxins in herb tea and medicinal plants, European Journal of Epidemiology, Netherlands, vol. 14/issue 3, pp. 269-274, 1998.

  8. . Hamburger M., Adler S., Baumann D., Förg A., Weinreich B. Preparative purification of the major anti -inflammatory triterpenoid esters from Marigold (Calendula officinalis), Fitoterapia, Netherlands, vol. 74/Issue 4, pp. 328-338, 2003.

  9. . Mishra A.K., Mishra A., Chattopadhyay P. Assessment of in vitro sun protection factor of Calendula officinalis L. ( Asteraceae) essential oil formulation , Journal of Young Pharmacists, India, Volume 4/Issue 1, pp. 17-21, 2012.

  10. . European Pharmacopoeia, 6th Edition, France, EDQM, Strasbourg, 2007, pp. 2340-2344.

  11. . Behtash N., Shafaroudi H., Nazari Khorasgani Z. Analgesic effect of Calendula officinalis flowers extract in mice, Toxicology Letters, Ireland, vol. 196/Supplement, pp. S251, 2010.

  12. . Bugno A., Almodovar B., Aparecida A., Pereira Caldas T et al. Occurence of toxigenic fungi in herbal drugs, Brazilian Journal of Microbiology, Brazil, vol. 37, pp. 47-51, 2006, 37.

  13. . Cordova C.A., Siqueira I.R., Netto Ca., Yunes R.A. et al. Protective properties of butanolic extract of the Calendula officinalis L. (marigold) against lipid peroxidation of rat liver microsomes and action as free radical scavanger, Redox Report, Australia, vol. 7/issue 2, pp. 95-102, 2002.

  14. . Czech E., Kneifel W., Kopp B. Microbiological status of commercially available medicinal drugs-a screening study, Planta Medica, Germany, vol. 67/issue 3, pp. 263- 269, 2001.

  15. . Efstratiou E., Abdullah I.H., Poonam S.N., Moore J.E., Muhammad A.A., Juluri R.R. Antimicrobial activity of Calendula officinalis petal extracts against fungi, as well as Gram-negative and Gram -positive clinical pathogens, Complementary Therapies i n Clinical Practice, United Kingdom, Vol. 18/Issue 3, pp. 173-176, 2012.

  16. . Goncalez E., Felicio J.D., Pinto M.M. Bioflavonoids inhibit the production of aflatoxin by Aspergillus flavus, Brazilian Journal of Medical and Biological Research, Brazil, vol. 34/issue 11, pp. 1453-1456, 2001.

  17. . Halt M. Moulds and mycotoxins in herb tea and medicinal plants, European Journal of Epidemiology, Netherlands, vol. 14/issue 3, pp. 269-274, 1998.

  18. . Hamburger M., Adler S., Baumann D., Förg A., Weinreich B. Preparative purification of the major anti -inflammatory triterpenoid esters from Marigold (Calendula officinalis), Fitoterapia, Netherlands, vol. 74/Issue 4, pp. 328-338, 2003.

  19. . Mishra A.K., Mishra A., Chattopadhyay P. Assessment of in vitro sun protection factor of Calendula officinalis L. ( Asteraceae) essential oil formulation , Journal of Young Pharmacists, India, Volume 4/Issue 1, pp. 17-21, 2012.

  20. . European Pharmacopoeia, 6th Edition, France, EDQM, Strasbourg, 2007, pp. 2340-2344.

View or Download full articleAccess options
Full paper accessChoose SWS login, librarian support, or instant article download.

SWS access login

Login as SWS Scientific Committee

Authors and approved SWS contributors will read and export their own linked papers after identity matching by SWS profile, email and SGEM GlobalID.

For librarian assistance: [email protected]

Purchase Instant Access

48-hour online accessComing soon
Online-only accessComing soon
Download the full article in PDF formatEUR 35
  • Article can be downloaded after successful payment.
  • Article may be used according to SWS library access terms.
  • Article cannot be redistributed.
Get full paper

Back to publication list